- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
According to this latest study, the 2020 growth of Biosimilar Drug will have significant change from previous year. By the most conservative estimates of global Biosimilar Drug market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Biosimilar Drug market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Biosimilar Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Injection
Tablets
Other Types
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Ankylosing Spondylitis
Tumor
Rheumatoid Arthrtis
Cardiovascular
Other Application
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Amgen
Eli Lilly
Novartis
CP Guojian Pharma
Biotech Pharma
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Biosimilar Drug Consumption 2016-2026
2.1.2 Biosimilar Drug Consumption CAGR by Region
2.2 Biosimilar Drug Segment by Type
2.2.1 Injection
2.2.2 Tablets
2.2.3 Other Types
2.3 Biosimilar Drug Sales by Type
2.3.1 Global Biosimilar Drug Sales Market Share by Type (2016-2021)
2.3.2 Global Biosimilar Drug Revenue and Market Share by Type (2016-2021)
2.3.3 Global Biosimilar Drug Sale Price by Type (2016-2021)
2.4 Biosimilar Drug Segment by Application
2.4.1 Ankylosing Spondylitis
2.4.2 Tumor
2.4.3 Rheumatoid Arthrtis
2.4.4 Cardiovascular
2.4.5 Other Application
2.5 Biosimilar Drug Sales by Application
2.5.1 Global Biosimilar Drug Sale Market Share by Application (2016-2021)
2.5.2 Global Biosimilar Drug Revenue and Market Share by Application (2016-2021)
2.5.3 Global Biosimilar Drug Sale Price by Application (2016-2021)
3 Global Biosimilar Drug by Company
3.1 Global Biosimilar Drug Sales Market Share by Company
3.1.1 Global Biosimilar Drug Sales by Company (2019-2021)
3.1.2 Global Biosimilar Drug Sales Market Share by Company (2019-2021)
3.2 Global Biosimilar Drug Revenue Market Share by Company
3.2.1 Global Biosimilar Drug Revenue by Company (2019-2021)
3.2.2 Global Biosimilar Drug Revenue Market Share by Company (2019-2021)
3.3 Global Biosimilar Drug Sale Price by Company
3.4 Global Manufacturers Biosimilar Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Biosimilar Drug Product Location Distribution
3.4.2 Players Biosimilar Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Biosimilar Drug by Region
4.1 Global Biosimilar Drug by Region
4.1.1 Global Biosimilar Drug Sales by Region
4.1.2 Global Biosimilar Drug Revenue by Region
4.2 Americas Biosimilar Drug Sales Growth
4.3 APAC Biosimilar Drug Sales Growth
4.4 Europe Biosimilar Drug Sales Growth
4.5 Middle East & Africa Biosimilar Drug Sales Growth
5 Americas
5.1 Americas Biosimilar Drug Sales by Country
5.1.1 Americas Biosimilar Drug Sales by Country (2016-2021)
5.1.2 Americas Biosimilar Drug Revenue by Country (2016-2021)
5.2 Americas Biosimilar Drug Sales by Type
5.3 Americas Biosimilar Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biosimilar Drug Sales by Region
6.1.1 APAC Biosimilar Drug Sales by Region (2016-2021)
6.1.2 APAC Biosimilar Drug Revenue by Region (2016-2021)
6.2 APAC Biosimilar Drug Sales by Type
6.3 APAC Biosimilar Drug Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Biosimilar Drug by Country
7.1.1 Europe Biosimilar Drug Sales by Country (2016-2021)
7.1.2 Europe Biosimilar Drug Revenue by Country (2016-2021)
7.2 Europe Biosimilar Drug Sales by Type
7.3 Europe Biosimilar Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Biosimilar Drug by Country
8.1.1 Middle East & Africa Biosimilar Drug Sales by Country (2016-2021)
8.1.2 Middle East & Africa Biosimilar Drug Revenue by Country (2016-2021)
8.2 Middle East & Africa Biosimilar Drug Sales by Type
8.3 Middle East & Africa Biosimilar Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Biosimilar Drug Distributors
10.3 Biosimilar Drug Customer
11 Global Biosimilar Drug Market Forecast
11.1 Global Biosimilar Drug Forecast by Region
11.1.1 Global Biosimilar Drug Forecast by Regions (2021-2026)
11.2.2 Global Biosimilar Drug Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Biosimilar Drug Forecast by Type
11.7 Global Biosimilar Drug Forecast by Application
12 Key Players Analysis
12.1 Amgen
12.1.1 Amgen Amgen Company Information
12.1.2 Amgen Biosimilar Drug Product Offered
12.1.3 Amgen Biosimilar Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Amgen Main Business Overview
12.1.5 Amgen Latest Developments
12.2 Eli Lilly
12.2.1 Eli Lilly Company Information
12.2.2 Eli Lilly Biosimilar Drug Product Offered
12.2.3 Eli Lilly Biosimilar Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Eli Lilly Main Business Overview
12.2.5 Eli Lilly Latest Developments
12.3 Novartis
12.3.1 Novartis Company Information
12.3.2 Novartis Biosimilar Drug Product Offered
12.3.3 Novartis Biosimilar Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Novartis Main Business Overview
12.3.5 Novartis Latest Developments
12.4 CP Guojian Pharma
12.4.1 CP Guojian Pharma Company Information
12.4.2 CP Guojian Pharma Biosimilar Drug Product Offered
12.4.3 CP Guojian Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 CP Guojian Pharma Main Business Overview
12.4.5 CP Guojian Pharma Latest Developments
12.5 Biotech Pharma
12.5.1 Biotech Pharma Company Information
12.5.2 Biotech Pharma Biosimilar Drug Product Offered
12.5.3 Biotech Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Biotech Pharma Main Business Overview
12.5.5 Biotech Pharma Latest Developments
...
13 Research Findings and Conclusion
List of Tables
Table 1. Biosimilar Drug Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Injection
Table 3. Major Players of Tablets
Table 4. Major Players of Other Types
Table 5. Global Biosimilar Drug Sales by Type (2016-2021) & (K Dose)
Table 6. Global Biosimilar Drug Sales Market Share by Type (2016-2021)
Table 7. Global Biosimilar Drug Revenue by Type (2016-2021) & ($ million)
Table 8. Global Biosimilar Drug Revenue Market Share by Type (2016-2021)
Table 9. Global Biosimilar Drug Sale Price by Type (2016-2021)
Table 10. Global Biosimilar Drug Sales by Application (2016-2021) & (K Dose)
Table 11. Global Biosimilar Drug Sales Market Share by Application (2016-2021)
Table 12. Global Biosimilar Drug Value by Application (2016-2021)
Table 13. Global Biosimilar Drug Revenue Market Share by Application (2016-2021)
Table 14. Global Biosimilar Drug Sale Price by Application (2016-2021)
Table 15. Global Biosimilar Drug Sales by Company (2019-2021) & (K Dose)
Table 16. Global Biosimilar Drug Sales Market Share by Company (2019-2021)
Table 17. Global Biosimilar Drug Revenue by Company (2019-2021) ($ Millions)
Table 18. Global Biosimilar Drug Revenue Market Share by Company (2019-2021)
Table 19. Global Biosimilar Drug Sale Price by Company (2019-2021)
Table 20. Key Manufacturers Biosimilar Drug Producing Area Distribution and Sales Area
Table 21. Players Biosimilar Drug Products Offered
Table 22. Biosimilar Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Biosimilar Drug Sales by Region (2016-2021) (K Dose)
Table 26. Global Biosimilar Drug Sales Market Share by Region (2016-2021)
Table 27. Global Biosimilar Drug Revenue by Region (2016-2021) & ($ Millions)
Table 28. Global Biosimilar Drug Revenue Market Share by Region (2016-2021)
Table 29. Americas Biosimilar Drug Sales by Country (2016-2021) & (K Dose)
Table 30. Americas Biosimilar Drug Sales Market Share by Country (2016-2021)
Table 31. Americas Biosimilar Drug Revenue by Country (2016-2021) & ($ Millions)
Table 32. Americas Biosimilar Drug Revenue Market Share by Country (2016-2021)
Table 33. Americas Biosimilar Drug Sales by Type (2016-2021) & (K Dose)
Table 34. Americas Biosimilar Drug Sales Market Share by Type (2016-2021)
Table 35. Americas Biosimilar Drug Sales by Application (2016-2021) & (K Dose)
Table 36. Americas Biosimilar Drug Sales Market Share by Application (2016-2021)
Table 37. APAC Biosimilar Drug Sales by Region (2016-2021) & (K Dose)
Table 38. APAC Biosimilar Drug Sales Market Share by Region (2016-2021)
Table 39. APAC Biosimilar Drug Revenue by Region (2016-2021) & ($ Millions)
Table 40. APAC Biosimilar Drug Revenue Market Share by Region (2016-2021)
Table 41. APAC Biosimilar Drug Sales by Type (2016-2021) & (K Dose)
Table 42. APAC Biosimilar Drug Sales Market Share by Type (2016-2021)
Table 43. APAC Biosimilar Drug Sales by Application (2016-2021) & (K Dose)
Table 44. APAC Biosimilar Drug Sales Market Share by Application (2016-2021)
Table 45. Europe Biosimilar Drug Sales by Country (2016-2021) & (K Dose)
Table 46. Europe Biosimilar Drug Sales Market Share by Country (2016-2021)
Table 47. Europe Biosimilar Drug Revenue by Country (2016-2021) & ($ Millions)
Table 48. Europe Biosimilar Drug Revenue Market Share by Country (2016-2021)
Table 49. Europe Biosimilar Drug Sales by Type (2016-2021) & (K Dose)
Table 50. Europe Biosimilar Drug Sales Market Share by Type (2016-2021)
Table 51. Europe Biosimilar Drug Sales by Application (2016-2021) & (K Dose)
Table 52. Europe Biosimilar Drug Sales Market Share by Application (2016-2021)
Table 53. Middle East & Africa Biosimilar Drug Sales by Country (2016-2021) & (K Dose)
Table 54. Middle East & Africa Biosimilar Drug Sales Market Share by Country (2016-2021)
Table 55. Middle East & Africa Biosimilar Drug Revenue by Country (2016-2021) & ($ Millions)
Table 56. Middle East & Africa Biosimilar Drug Revenue Market Share by Country (2016-2021)
Table 57. Middle East & Africa Biosimilar Drug Sales by Type (2016-2021) & (K Dose)
Table 58. Middle East & Africa Biosimilar Drug Sales Market Share by Type (2016-2021)
Table 59. Middle East & Africa Biosimilar Drug Sales by Application (2016-2021) & (K Dose)
Table 60. Middle East & Africa Biosimilar Drug Sales Market Share by Application (2016-2021)
Table 61. Global Biosimilar Drug Sales Forecast by Type (2021-2026) & (K Dose)
Table 62. Global Biosimilar Drug Sales Market Share Forecast by Type (2021-2026)
Table 63. Global Biosimilar Drug Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 64. Global Biosimilar Drug Revenue Market Share Forecast by Type (2021-2026)
Table 65. Global Biosimilar Drug Sales Forecast by Application (2021-2026) & (K Dose)
Table 66. Global Biosimilar Drug Sales Market Share Forecast by Application (2021-2026)
Table 67. Global Biosimilar Drug Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 68. Global Biosimilar Drug Revenue Market Share Forecast by Application (2021-2026)
Table 69. Amgen Basic Information, Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors
Table 70. Amgen Biosimilar Drug Product Offered
Table 71. Amgen Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 72. Amgen Main Business
Table 73. Amgen Latest Developments
Table 74. Eli Lilly Basic Information, Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors
Table 75. Eli Lilly Biosimilar Drug Product Offered
Table 76. Eli Lilly Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 77. Eli Lilly Main Business
Table 78. Eli Lilly Latest Developments
Table 79. Novartis Basic Information, Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors
Table 80. Novartis Biosimilar Drug Product Offered
Table 81. Novartis Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 82. Novartis Main Business
Table 83. Novartis Latest Developments
Table 84. CP Guojian Pharma Basic Information, Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors
Table 85. CP Guojian Pharma Biosimilar Drug Product Offered
Table 86. CP Guojian Pharma Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 87. CP Guojian Pharma Main Business
Table 88. CP Guojian Pharma Latest Developments
Table 89. Biotech Pharma Basic Information, Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors
Table 90. Biotech Pharma Biosimilar Drug Product Offered
Table 91. Biotech Pharma Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 92. Biotech Pharma Main Business
Table 93. Biotech Pharma Latest Developments
List of Figures
Figure 1. Picture of Biosimilar Drug
Figure 2. Biosimilar Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Biosimilar Drug Sales Growth Rate 2016-2026 (K Dose)
Figure 7. Global Biosimilar Drug Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Biosimilar Drug Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Injection
Figure 10. Product Picture of Tablets
Figure 11. Product Picture of Other Types
Figure 12. Global Biosimilar Drug Sales Market Share by Type in 2020
Figure 13. Global Biosimilar Drug Revenue Market Share by Type (2016-2021)
Figure 14. Biosimilar Drug Consumed in Ankylosing Spondylitis
Figure 15. Global Biosimilar Drug Market: Ankylosing Spondylitis (2016-2021) & (K Dose)
Figure 16. Biosimilar Drug Consumed in Tumor
Figure 17. Global Biosimilar Drug Market: Tumor (2016-2021) & (K Dose)
Figure 18. Biosimilar Drug Consumed in Rheumatoid Arthrtis
Figure 19. Global Biosimilar Drug Market: Rheumatoid Arthrtis (2016-2021) & (K Dose)
Figure 20. Biosimilar Drug Consumed in Cardiovascular
Figure 21. Global Biosimilar Drug Market: Cardiovascular (2016-2021) & (K Dose)
Figure 22. Biosimilar Drug Consumed in Other Application
Figure 23. Global Biosimilar Drug Market: Other Application (2016-2021) & (K Dose)
Figure 24. Global Biosimilar Drug Sales Market Share by Application (2016-2021)
Figure 25. Global Biosimilar Drug Revenue Market Share by Application in 2020
Figure 26. Global Biosimilar Drug Revenue Market by Company in 2020 ($ Million)
Figure 27. Global Biosimilar Drug Revenue Market Share by Company in 2020
Figure 28. Global Biosimilar Drug Sales Market Share by Regions (2016-2021)
Figure 29. Global Biosimilar Drug Revenue Market Share by Region in 2020
Figure 30. Americas Biosimilar Drug Sales 2016-2021 (K Dose)
Figure 31. Americas Biosimilar Drug Revenue 2016-2021 ($ Millions)
Figure 32. APAC Biosimilar Drug Sales 2016-2021 (K Dose)
Figure 33. APAC Biosimilar Drug Revenue 2016-2021 ($ Millions)
Figure 34. Europe Biosimilar Drug Sales 2016-2021 (K Dose)
Figure 35. Europe Biosimilar Drug Revenue 2016-2021 ($ Millions)
Figure 36. Middle East & Africa Biosimilar Drug Sales 2016-2021 (K Dose)
Figure 37. Middle East & Africa Biosimilar Drug Revenue 2016-2021 ($ Millions)
Figure 38. Americas Biosimilar Drug Sales Market Share by Country in 2020
Figure 39. Americas Biosimilar Drug Revenue Market Share by Country in 2020
Figure 40. Americas Biosimilar Drug Sales Market Share by Type in 2020
Figure 41. Americas Biosimilar Drug Sales Market Share by Application in 2020
Figure 42. United States Biosimilar Drug Revenue Growth 2016-2021 ($ Millions)
Figure 43. Canada Biosimilar Drug Revenue Growth 2016-2021 ($ Millions)
Figure 44. Mexico Biosimilar Drug Revenue Growth 2016-2021 ($ Millions)
Figure 45. Brazil Biosimilar Drug Revenue Growth 2016-2021 ($ Millions)
Figure 46. APAC Biosimilar Drug Sales Market Share by Region in 2020
Figure 47. APAC Biosimilar Drug Revenue Market Share by Regions in 2020
Figure 48. APAC Biosimilar Drug Sales Market Share by Type in 2020
Figure 49. APAC Biosimilar Drug Sales Market Share by Application in 2020
Figure 50. China Biosimilar Drug Revenue Growth 2016-2021 ($ Millions)
Figure 51. Japan Biosimilar Drug Revenue Growth 2016-2021 ($ Millions)
Figure 52. Korea Biosimilar Drug Revenue Growth 2016-2021 ($ Millions)
Figure 53. Southeast Asia Biosimilar Drug Revenue Growth 2016-2021 ($ Millions)
Figure 54. India Biosimilar Drug Revenue Growth 2016-2021 ($ Millions)
Figure 55. Australia Biosimilar Drug Revenue Growth 2016-2021 ($ Millions)
Figure 56. Europe Biosimilar Drug Sales Market Share by Country in 2020
Figure 57. Europe Biosimilar Drug Revenue Market Share by Country in 2020
Figure 58. Europe Biosimilar Drug Sales Market Share by Type in 2020
Figure 59. Europe Biosimilar Drug Sales Market Share by Application in 2020
Figure 60. Germany Biosimilar Drug Revenue Growth 2016-2021 ($ Millions)
Figure 61. France Biosimilar Drug Revenue Growth 2016-2021 ($ Millions)
Figure 62. UK Biosimilar Drug Revenue Growth 2016-2021 ($ Millions)
Figure 63. Italy Biosimilar Drug Revenue Growth 2016-2021 ($ Millions)
Figure 64. Russia Biosimilar Drug Revenue Growth 2016-2021 ($ Millions)
Figure 65. Middle East & Africa Biosimilar Drug Sales Market Share by Country in 2020
Figure 66. Middle East & Africa Biosimilar Drug Revenue Market Share by Country in 2020
Figure 67. Middle East & Africa Biosimilar Drug Sales Market Share by Type in 2020
Figure 68. Middle East & Africa Biosimilar Drug Sales Market Share by Application in 2020
Figure 69. Egypt Biosimilar Drug Revenue Growth 2016-2021 ($ Millions)
Figure 70. South Africa Biosimilar Drug Revenue Growth 2016-2021 ($ Millions)
Figure 71. Israel Biosimilar Drug Revenue Growth 2016-2021 ($ Millions)
Figure 72. Turkey Biosimilar Drug Revenue Growth 2016-2021 ($ Millions)
Figure 73. GCC Country Biosimilar Drug Revenue Growth 2016-2021 ($ Millions)
Figure 74. Channels of Distribution
Figure 75. Distributors Profiles
Please feel free to write an email to us or to use our electronic ticketing system.
